Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 EUR | +2.16% | +2.16% | -12.71% |
Apr. 22 | Pharming Group to Buy Back EUR123 Million of Bonds due 2025 | MT |
Apr. 18 | Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds | MT |
Sales 2024 * | 262M 280M | Sales 2025 * | 300M 321M | Capitalization | 606M 648M |
---|---|---|---|---|---|
Net income 2024 * | 1M 1.07M | Net income 2025 * | 14M 14.97M | EV / Sales 2024 * | 1.97 x |
Net cash position 2024 * | 90.86M 97.15M | Net cash position 2025 * | 119M 128M | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
-300
x | P/E ratio 2025 * |
40.9
x | Employees | 382 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Pharming Group N.V.
1 day | +2.16% | ||
1 week | +2.16% | ||
Current month | -11.68% | ||
1 month | -11.07% | ||
3 months | -22.48% | ||
6 months | -17.81% | ||
Current year | -12.71% |
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 20-11-15 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.05% | 7 M€ | -.--% | - | |
0.02% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.9 | +2.16% | 3,641,122 |
24-04-25 | 0.881 | -2.60% | 4,203,859 |
24-04-24 | 0.9045 | -0.39% | 6,519,524 |
24-04-23 | 0.908 | +0.89% | 4,300,077 |
24-04-22 | 0.9 | +2.16% | 6,570,354 |
Real-time Euronext Amsterdam, April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.71% | 647M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PHARM Stock